SPC469
Zilucoplan
Status:
VeittApplication date:
30.5.2024Application published:
15.6.2024Grant published:
15.12.2025
Max expiry date:
3.12.2038Medicine name:
ZilbrysqMedicine for children:
No
Timeline
Today
30.5.2024Application
15.6.2024Publication
15.12.2025Registration
3.12.2038Expires
Marketing license
IS authorization number:
EU/1/23/1764Date:
15.12.2023
Foreign authorization number:
EU/1/23/1764Date:
1.12.2023
Owner
Name:
UCB Holdings, Inc.Address:
1950 Lake Park Drive, Smyrna, GA 30080 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3154561
Deadlines
TypeDeadline until
Type: Frestur til að fara yfir drög að vottorði
Deadline until: 22.11.2025